Why is JNJ considered a bulletproof dividend stock?

Due to its diversified business and stable cash flows, the company continues to raise dividends even in tough times.

What risks does Johnson & Johnson face?

Potential risks include litigation and regulatory changes that could impact performance.

Johnson & Johnson: The Closest Thing to a Bulletproof Dividend Stock

A Motley Fool article highlights Johnson & Johnson's (JNJ) strength as a defensive investment, with the company continuing to raise its dividend despite economic challenges.

June 6, 2026

2 min read

Source: Motley Fool

Johnson & Johnson (JNJ) is one of the leading companies in the healthcare sector, renowned for its reliable dividend stock status. According to a Motley Fool analysis, JNJ may be the closest thing investors can find to a "bulletproof" dividend stock, as it consistently raises its payout year after year.

Details

Johnson & Johnson boasts a diversified business portfolio spanning pharmaceuticals, medical devices, and consumer health products, providing stable cash flows even during downturns. The company has increased its dividend for 59 consecutive years, making it a member of the elite Dividend Aristocrats group.

Context

In today's volatile market environment with economic uncertainty, investors seek defensive assets that offer steady income. Johnson & Johnson stands out as an attractive option due to its financial strength and long history of dividend growth.

What This Means for Investors

For investors seeking stable income and long-term growth, JNJ represents a strong defensive choice. However, potential risks such as litigation or regulatory changes should be considered.

Frequently Asked Questions

The company has increased its dividend for 59 consecutive years.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.